about
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American CoPrimary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes AssociationQuick assessment of literacy in primary care: the newest vital signIdentification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometryPhysicians' ability to predict the risk of coronary heart diseaseA primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidityColorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communicationWhat does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease riskDevelopment and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice.A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation?Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary preventionCardiovascular disorders. Primary preventionAn editorial update: should she take aspirin?Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task ForceAspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysisThe impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trialA randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetesAspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysisAspirin use among adults aged 40 and older in the United States: results of a national surveyDevelopment and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions.Assessing the quality of initial consultations regarding adjuvant colon cancer therapyThe effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial.Should a colon cancer screening decision aid include the option of no testing? A comparative trial of two decision aids.European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial.Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study.Numeracy and the medical student's ability to interpret data.Comparison of a one-time educational intervention to a teach-to-goal educational intervention for self-management of heart failure: design of a randomized controlled trialData sources for measuring colorectal endoscopy use among Medicare enrollees.A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial [ISRCTN11535170].Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities.The effect of health literacy on knowledge and receipt of colorectal cancer screening: a survey studyValue of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study.Development and validation of the Diabetes Numeracy Test (DNT)Yield of claims data and surveys for determining colon cancer screening among health plan members.Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy.Patient time requirements for anticoagulation therapy with warfarin.The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial.
P50
Q22241289-0C32D468-86AE-46E8-AF36-1D4ACA013745Q22241916-481A3486-8A4D-43AA-BBF9-1567755BB456Q24544727-7D1F3C28-A5DA-4232-B088-493981D88ECDQ24549069-6C98D401-1187-4F27-8B50-43778AD43933Q24793988-B10AD017-244A-416F-8D8C-52AFC0772FDBQ24795358-889F2950-4386-46BE-BFC9-23448AA9C219Q24801564-6A23C469-B9D2-48A2-8079-71D3F624AEBEQ24804500-374E2E12-8195-4AF0-A379-EF4FD6B6607DQ24813969-D2BC420C-553A-4F97-ADD8-DF50FC0F5FE7Q27022198-0B6EACDF-74C7-4A11-A78C-2B41CB39301AQ28167662-DD238EDB-30F2-44A8-8C77-C16F1E77A010Q28168472-59D181AF-219B-46C0-8225-EA2D94E151CDQ28176787-CCCE77A5-EE3B-4CC2-8F80-AE54ED3CB870Q28192096-1F505244-4C9E-4C47-9F99-DF0EEF6C8461Q28195576-D3D4D847-46BB-4DD8-A740-F9B7AB0EC4C9Q28200559-05C483F2-4E11-4442-AB56-4ECC6C7F90BBQ28218457-C15062DF-F027-4B94-83CC-C9E09221C34EQ28218996-F48933F5-24E7-4288-8B0A-4E845EAA4C90Q28222804-36DCDDB4-B297-43E0-A771-3D2878F9363AQ30411130-1DC004D5-2983-4327-AA6F-C9F9980BF5ABQ30435841-03E5CC54-EDE4-4F25-B5F4-8E385CC55845Q30481376-2ABCF174-366E-4048-B8A6-443C282A0EC3Q30481547-A10CFD60-44AC-4C3A-ADD4-3B87A4342019Q30485842-575A9752-44CB-4239-A29C-84EF1CBDC9E7Q30573421-ACE8AB5E-A474-4F6E-8342-ADF39C72FB11Q30574651-5C6DCFE3-932B-4BC9-99D5-166E21D24535Q30585262-E20B49A2-7479-4700-B431-0B20DE908E58Q30677269-E1517563-99EF-43B9-916A-08F27C06B8EEQ30865283-F78A585C-6F8F-417D-9ADA-3F1150BBDE30Q31132910-2FEF0220-30B7-4D9D-A9F0-1CA79EA38182Q33236256-97926794-9DA8-4444-B5D6-D9E0DFD85EFBQ33238894-4F557C7A-73A7-4CE4-9730-4BF4E66B213CQ33252752-99339E75-ED02-43E6-8B9C-7AF43A45752BQ33280511-569FACB2-5EE6-4E48-99AF-6E60C8FB9342Q33319064-EB8F0E1D-BE89-4493-8A48-6AEBA51DE46CQ33331477-D4DCF5EA-1B89-4F15-9595-AA380EEB4602Q33416348-49E428E8-8F8B-4EE4-91F1-67952BCB4991Q33499403-0EF9F22D-6D78-4D83-A73B-E8B0D20B7DE0Q33505924-7502BFEB-29BD-4A1F-A88F-FC4BB81FC45FQ33581790-57AACAE8-AB44-4AA4-8615-0D1985B99E79
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michael P. Pignone
@ast
Michael P. Pignone
@en
Michael P. Pignone
@es
Michael P. Pignone
@nl
Michael P. Pignone
@sl
type
label
Michael P. Pignone
@ast
Michael P. Pignone
@en
Michael P. Pignone
@es
Michael P. Pignone
@nl
Michael P. Pignone
@sl
altLabel
Michael P Pignone
@en
Michael Pignone
@en
prefLabel
Michael P. Pignone
@ast
Michael P. Pignone
@en
Michael P. Pignone
@es
Michael P. Pignone
@nl
Michael P. Pignone
@sl
P214
P244
P106
P21
P214
P244
no2005034129
P31
P496
0000-0002-6657-7342
P734
P735
P7859
lccn-no2005034129